As of 2026-09-13, the Relative Valuation of Aclaris Therapeutics Inc (ACRS) is (7.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Aclaris Therapeutics Inc based on Relative Valuation is -233.5%.
The range of the Relative Valuation is (6.11) - (9.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 20.6x | 12.8x |
| Forward P/E multiples | 11.0x - 17.8x | 13.4x |
| Fair Price | (6.11) - (9.63) | (7.10) |
| Upside | -214.8% - -281.0% | -233.5% |
| Date | P/E |
| 2026-09-09 | -10.02 |
| 2026-09-08 | -11.17 |
| 2026-09-04 | -11.38 |
| 2026-09-03 | -10.97 |
| 2026-09-02 | -11.40 |
| 2026-09-01 | -11.10 |
| 2026-08-31 | -11.16 |
| 2026-08-28 | -11.08 |
| 2026-08-27 | -11.36 |
| 2026-08-26 | -11.41 |
| 2026-08-25 | -12.05 |
| 2026-08-24 | -11.64 |
| 2026-08-21 | -11.82 |
| 2026-08-20 | -11.67 |
| 2026-08-19 | -11.88 |
| 2026-08-18 | -11.63 |
| 2026-08-17 | -10.92 |
| 2026-08-14 | -10.66 |
| 2026-08-13 | -10.81 |
| 2026-08-12 | -10.77 |
| 2026-08-11 | -10.92 |
| 2026-08-10 | -10.88 |
| 2026-08-07 | -10.90 |
| 2026-08-06 | -11.23 |
| 2026-08-05 | -11.73 |
| 2026-08-04 | -11.03 |
| 2026-08-03 | -10.20 |
| 2026-07-31 | -9.59 |
| 2026-07-30 | -9.81 |
| 2026-07-29 | -9.44 |
| 2026-07-28 | -9.83 |
| 2026-07-27 | -9.90 |
| 2026-07-24 | -9.64 |
| 2026-07-23 | -10.11 |
| 2026-07-22 | -10.36 |
| 2026-07-21 | -10.49 |
| 2026-07-20 | -10.27 |
| 2026-07-17 | -10.47 |
| 2026-07-16 | -9.88 |
| 2026-07-15 | -10.33 |
| 2026-07-14 | -10.01 |
| 2026-07-13 | -10.14 |
| 2026-07-10 | -10.29 |
| 2026-07-09 | -10.53 |
| 2026-07-08 | -10.16 |
| 2026-07-07 | -10.36 |
| 2026-07-06 | -10.12 |
| 2026-07-02 | -10.25 |
| 2026-07-01 | -9.85 |
| 2026-06-30 | -9.75 |